STOCK INFO
NASDAQYI
Latest Releases
Sep 4, 2020

On August 25, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a company dedicated to digitally connecting patients with drugs and healthcare services in China, and Guangzhou Baiyunshan...

All Press Releases

Earnings

111, Inc. Executive Summary

Q2 2020 Earnings Webcast
Q2 2020 Earnings Release
 

CORPORATE PROFILE

111, Inc. listed on NASDAQ (YI:US) is a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services in China.

The Company provides millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy 1 Drugstore and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service and patient management service. In addition, the Company's online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides omni-channel support to its strategic partners in their drug commercialization effort, with services such as digital marketing, patient education, data analytics and pricing monitoring.

View All>

 

Company Introduction

 

IR Contacts

Primary IR Contact

GCM Strategic Communications

111, Inc.
E-mail: ir@111.com.cn

IR Counsel
E-mail: 111.ir@gcm.international

Information Request

If you would like to recieve our Investor Relations Packet,

including reprints of scientific publications relating to our products,

click here. Thank you for your interest.